Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Unavailable
    A Practical Guide to Rational Drug Design
    Unavailable
    A Practical Guide to Rational Drug Design
    Unavailable
    A Practical Guide to Rational Drug Design
    Ebook552 pages9 hours

    A Practical Guide to Rational Drug Design

    By Sun Hongmao

    ()

    Currently unavailable

    Currently unavailable

    About this ebook

    This book is not going to be an exhaustive survey covering all aspects of rational drug design. Instead, it is going to provide critical know-how through real-world examples. Relevant case studies will be presented and analyzed to illustrate the following: how to optimize a lead compound whether one has high or low levels of structural information; how to derive hits from competitors’ active compounds or from natural ligands of the targets; how to springboard from competitors’ SAR knowledge in lead optimization; how to design a ligand to interfere with protein-protein interactions by correctly examining the PPI interface; how to circumvent IP blockage using data mining; how to construct and fully utilize a knowledge-based molecular descriptor system; how to build a reliable QSAR model by focusing on data quality and proper selection of molecular descriptors and statistical approaches. A Practical Guide to Rational Drug Design focuses on computational drug design, with only basic coverage of biology and chemistry issues, such as assay design, target validation and synthetic routes.

    • Discusses various tactics applicable to daily drug design
    • Readers can download the materials used in the book, including structures, scripts, raw data, protocols, and codes, making this book suitable resource for short courses or workshops
    • Offers a unique viewpoint on drug discovery research due to the author’s cross-discipline education background
    • Explores the author’s rich experiences in both pharmaceutical and academic settings
    LanguageEnglish
    PublisherElsevier Science
    Release dateOct 5, 2015
    ISBN9780081001059
    Unavailable
    A Practical Guide to Rational Drug Design
    Author

    Sun Hongmao

    Dr. Sun received his BSc degree in chemistry and PhD degree in physics from University of Science and Technology of China (USTC). He was awarded his second PhD degree in medicinal and computational chemistry by Clark University and UMass Med School in 1997. Dr. Sun joined the faculty of Washington University Medical School at St. Louis in 1998. One and half years later, he became a computational scientist at Roche, where he spent over ten years to support dozens of rational drug design projects in such therapeutic areas as oncology, diabetes, obesity, virology, cardiovascular disease, etc. He is a well-recognized scholar in the field of drug discovery and ADMET predictions. His QSAR model ranked the first place in the Solubility Challenge. Dr. Sun and his colleagues also delivered the most accurate model in the GPCR homology modeling contest. Dr. Sun has published over 20 first and/or corresponding author peer-reviewed research papers, including 8 invited review articles covering different aspects of drug discovery. Dr. Sun was listed as Honorable Editor of three premium journals in the field of drug discovery and chemoinformatics.

    Related to A Practical Guide to Rational Drug Design

    Related ebooks

    Computers For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      For Better Diagnosis, Watch Proteins Fold In Real-time

      Jun 10, 2018

      10A new method can examine protein assembly in real time, in living cells, to find problems in the process and diagnose the resulting diseases, according to new research. Proteins in the body need to be perfectly arranged, or folded, to do their jobs

      2 min read

    • Article

      Opinion: Real-world Evidence Is Changing The Way We Study Drug Safety And Effectiveness

      Jan 29, 2019

      Instead of waiting for fleshed-out protocols for using real-world evidence, pharmaceutical companies should dive in now using a commonsense approach that relies on rigor and reason.

      4 min read

    • Article

      These Compounds Starve Blood Cancer To Death

      Jan 2, 2018

      Newly synthesized compounds can starve multiple myeloma—a rare form of blood cancer—to death, according to a series of studies using patient samples. The new compounds offer “a new strategy for attacking multiple myeloma…” Tumor cells, including thos

      2 min read

    • Article

      Opinion: The Trouble With Mice As Behavioral Models For Alzheimer’s And Other Neurologic Diseases

      Apr 16, 2019

      There's too much reliance on using mice as behavioral models to guide drug development for #Alzheimers and other neurologic diseases. We need to find ways to move beyond this flawed…

      4 min read

    • Article

      Opinion: All Study Participants Have A Right To Know Their Own Results. My Lab Has Been Doing That For Years

      Sep 5, 2018

      Giving study participants their individual results can drive greater public participation in research, increased support for science, and better health.

      6 min read

    • Article

      Opinion: Enough With The Me-too Drugs. New Treatments Should Be Worthy Of The People Who Invest Their Lives In Clinical Trials

      Sep 4, 2019

      Drug developers should should treat patients who volunteer for clinical trials the way they would treat their mothers or husbands or best friends — but often don't.

      3 min read

    • Article

      Opinion: AI Will Revolutionize Drug Discovery — But Only If Experts Are Involved

      Nov 1, 2019

      To fruitfully apply AI to drug discovery, we need better feedback loops between developers and interdisciplinary teams that test the technology.

      4 min read

    • Article

      Opinion: Manufacturing: The Next Breakthrough In Gene Therapy

      Dec 18, 2019

      As the race heats up to bring gene therapy to market, breakthroughs in manufacturing are often the key — or break down the barrier — to delivering these therapies to…

      3 min read

    • Article

      Broccoli-Based Compound May Treat Melanoma

      Jul 25, 2017

      A new compound may lead to a drug that can destroy melanoma cancer cells while leaving nearby healthy cells unharmed, new research on mice and human cells indicates. …the compound caused human melanoma cells to die and inhibited tumor growth by about

      2 min read

    • Article

      Machine Learning Predicts How Drugs Will Affect Cancer Cells

      Oct 6, 2023

      A new approach can predict how individual cells react to specific treatments, offering hope for more accurate diagnoses and therapeutics. Cancer is triggered by changes in cells that lead to the proliferation of pathogenic tumor cells. In order to fi

      3 min read

    • Article

      Opinion: Drug Sensitivity And Resistance Testing Could Make ‘Right To Try’ A Real Thing

      Oct 9, 2018

      There's no catalog of available drugs that can help patients pursuing #RightToTry options. An updated technique once developed for cancer might match patients with experimental drugs.

      3 min read

    • Article

      Opinion: Machine Learning For Clinical Decision-making: Pay Attention To What You Don’t See

      Dec 12, 2019

      Don't take results from machine learning algorithms at face value. Ask what information isn't available. What subgroups haven't been prioritized? Who is on the research team?

      4 min read

    • Article

      Opinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials

      Feb 5, 2019

      Synthetic control arms aren't the solution to all of the challenges facing randomized trials, but they represent a great way for drug development companies to start using real-world evidence.

      4 min read

    • Article

      Could Time Of Day Boost Chemo For Glioblastoma?

      Jan 10, 2018

      Circadian rhythms could hold the key to novel therapies for glioblastoma, the most prevalent type of brain cancer in adults—and one with a grim prognosis. In research with cell cultures, scientists determined that the timed production of a particular

      3 min read

    • Article

      New Way To Study Protein Complexes Doesn’t Break Them Up

      Mar 23, 2018

      Researchers have developed a new way to study protein complexes. Proteins are the worker bees of the cell, mainly ganging up to form macromolecular, multicomponent complexes to perform intricate cellular tasks. “Proteins are the main drivers of prett

      2 min read

    • Article

      Injectable Goo Could Bring Drugs To Cancerous Tumors

      Feb 22, 2018

      An injectable gel-like scaffold can hold combination chemo-immunotherapeutic drugs and deliver them locally and sequentially to tumors. The results in animal models so far suggest this approach could eventually ramp up therapeutic benefits for patien

      3 min read

    • Article

      Opinion: A Bird’s-eye View Of Clinical Trials Provides New Perspectives On Drug Research And Development

      Jul 18, 2019

      A data visualization that reveals the forests and the trees of new drug clinical trials can help open up new possibilities for shaping the drug development landscape to better serve…

      6 min read

    • Article

      Team Discovers Roughly 100 Potential Cancer Culprits

      May 14, 2018

      Researchers have uncovered a number of proteins that could play a critical role propagating signals within cells that can lead to uncontrolled cell growth—one of the hallmarks of cancer. The study, which appears in Cell Reports, used mouse fibroblast

      2 min read

    Related categories

    Reviews for A Practical Guide to Rational Drug Design

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words